Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death

Published:2015-02-23 Issue:3 Volume:169 Page:423-434
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mishima Yuko¹,Santo Loredana¹,Eda Homare¹,Cirstea Diana¹,Nemani Neeharika¹,Yee Andrew J.¹,O'Donnell Elizabeth¹,Selig Martin Karl²,Quayle Steven N.³,Arastu-Kapur Shirin⁴,Kirk Christopher⁴,Boise Lawrence H.⁵,Jones Simon S.³,Raje Noopur¹

Affiliation:

1. Division of Hematology and Oncology; Massachusetts General Hospital Cancer Center; Harvard Medical School; Boston MA USA

2. Department of Pathology; Massachusetts General Hospital; Boston MA USA

3. Acetylon Pharmaceuticals, Inc.; Boston MA USA

4. Onyx Pharmaceuticals, Inc., an Amgen Subsidiary; South San Francisco CA USA

5. Winship Cancer Institute of Emory University School of Medicine; Atlanta GA USA

Funder

Prism, Onyx pharmaceuticals

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13315/fullpdf

Reference47 articles.

1. NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma;Catley;Blood,2003

2. JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells;Chauhan;Journal of Biological Chemistry,2003

3. Automatic and quantitative measurement of protein-protein colocalization in live cells;Costes;Biophysical Journal,2004

4. Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study;Dimopoulos;The Lancet Oncology,2013

5. Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa;Fribley;Journal of Biological Chemistry,2006

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and evaluation of a novel TRAIL-activated HDAC6 inhibitor for the treatment of pulmonary fibrosis;Bioorganic & Medicinal Chemistry;2024-09

2. Targeting the ubiquitin pathway in lymphoid malignancies;Cancer Letters;2024-07

3. HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapy;Cancer Immunology, Immunotherapy;2024-01

4. Design and synthesis of 1H-benzo[d]imidazole selective HDAC6 inhibitors with potential therapy for multiple myeloma;European Journal of Medicinal Chemistry;2023-12

5. Recent advancement of HDAC inhibitors against breast cancer;Medical Oncology;2023-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3